I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Promise and Progress - New Appointments and Arrivals
The Time is Now: 2010-2011
New Appointments and Arrivals
Date: November 11, 2010
Emmanuel S. Antonarakis, M.D., assistant professor of oncology, will focus on prostate cancer drug development and immunotherapy as a new addition to the genitourinary cancer program. He will use prognostic models of prostate cancer progression to design more informative clinical trials in men with localized or early relapsed prostate cancer. He received American Society of Clinical Oncology Young Investigator Award for his translational clinical trial exploring itraconazole in metastatic castrate-resistant, or androgen-independent, prostate cancer.
Martin Aryee, Ph.D., is a new member of the Cancer Center’s emerging Quantitative Sciences Program and Division of Biostatistics and Bioinformatics. He is a computational biologist focusing on molecular biology and cancer research and has developed analytical methods useful in cancer genetics and epigenetics research. Aryee also is a member of the Prostate Cancer Program.
Christine H. Chung, M.D., associate professor of oncology, was selected in a national search to lead our Center’s clinical research in head and neck cancer. She is studying EGFR inhibitors for the treatment of head and neck cancer. Chung also will be a collaborator in viral oncology research, researching the roles of the human papillomavirus (HPV) in the development of these cancers. She co-chairs the Eastern Cooperative Oncology Group Correlative Science and Translational Research Program and holds a similar leadership role for the Radiation Therapy Oncology Group. She is a member the NCI’s tumor biology and imaging task force of the head and neck cancer steering committee.
Ana De Jesus-Acosta, M.D., instructor in oncology, is a new member of our gastrointestinal cancer program. She will expand clinical research in pancreatic-biliary cancers and will focus on developing an early drug development clinical research program.
Nilanjan Ghosh, M.D., Ph.D., has joined the hematologic malignancies program as an instructor in oncology. He will develop a clinical research program in multiple myeloma and lymphoma.
Matthias Holdhoff, M.D., Ph.D., assistant professor of oncology, has joined the Kimmel Cancer Center’s Brain Cancer Program and Ludwig Center for Caner Genetics and Therapeutics. For the last three years, he has trained under Stuart Grossman, M.D., and Luis Diaz, M.D. As a clinical investigator, he will focus on the development of blood-based tumor markers and novel clinical trials for glioma and central nervous system(CNS) lymphoma.
Christian Meyer, M.D., Ph.D., instructor in oncology, has joined the Cancer Center faculty as the lead medical oncologist for the adult sarcoma and connective tissue oncology program. As a Kimmel Cancer Center fellow, Meyer was chief fellow of the Hematology and Medical Oncology training programs and, this year, received an American Society of Clinical Oncology Young Investigator Award.
Eric Schafer, M.D., instructor in oncology, is a new member of the pediatric oncology program. In addition to his clinical work, he will be doing laboratory research with Patrick Brown, M.D., to develop clinical trials for children with MLL gene-rearranged leukemias. Schafer competed and earned a spot in the Johns Hopkins Graduate Training Program in Clinical Investigation, and he was recently awarded a Young Investigator Award from Alex’s Lemonade Stand Foundation.
Robert Scharpf, Ph.D., has joined the Center’s Quantitative Sciences Program and Division of Biostatistics and Bioinformatics. His current research focuses on the development of improved methodologies for analysis of genomewide biological data. He will be taking a lead role in a reproducible research initiative aimed at providing tools that allow researchers easily share data and methods so that other scientists can reproduce and confirm their results.
Satish Shanbhag, M.D., M.P.H., has joined the Kimmel Cancer Center at Johns Hopkins Bayview as Clinical Director of Hematology. In addition to his training in oncology and hematology, Shanbhag holds Master of Public Health degree in health care organization and policy.
Articles in this Issue
Cover Story: Personalized Medicine is Here, The Time is Now
- Personalized Medicine is Here: The Time is Now
- Cover Story Sidebar: Our Cancer Research is Curing Other Diseases Too
- Cover Story Sidebar: A New Paradigm for Cancer Drug Discovery
- Cover Story Sidebar: Personalized Approaches in Pediatric Cancer
- Cover Story Sidebar: The Frankenstein Project
- Cover Story Sidebar: The Serendipitous Discovery of a Cancer Starter
- Cover Story Sidebar: The Mathematics of Curing Cancer
- Immune Cell Commander
- A Personalized Genetic Profile for Brain Cancer
- A New "Twist" in Breast Cancer
- JHU Engineering Student Invents Melanoma Screening Device
- Special Delivery: Biodegradable Particles Transport Drugs to Diseased Tissues and Organs
- Targeting Brain Cancer Stem Cells
- Vaccine Clears Out Leukemia Cells
- Does Low Cholesterol Equal Lower Risk of High-Grade Prostate Cancer?
- A Common Good - The Commonwealth Foundation
- Helping Us Solve The Cancer Puzzle
- The Skip Viragh Center
- Making Waves to Fight Cancer
- Gift Brings Complementary Care to Cancer Patients
- A Major Gift for Kidney Cancer Research
- Giant Food Supports Childhood Cancer Research
- Wawa Cares About Cancer Patients
- Young Lacrosse Players Faced Off Against Childhood Cancer